55 results on '"Maiero S"'
Search Results
2. T.09.4: GENOTYPE-PHENOTYPE CORRELATION FOR AGGRESSIVE GASTRIC AND DUODENAL LESIONS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS
3. T.09.7: PREDICTIVE VALUE OF COMBINED RISK SCORE FOR GASTRIC CANCER
4. V.01.7: A LAPAROSCOPIC AND ENDOSCOPIC COOPERATIVE SURGERY (LECS) APPROACH FOR TREATMENT OF APPENDICEAL LESION IN PATIENTS WITH SERRATED POLYPOSIS SYNDROME (SPS)
5. H. PYLORI INFECTION AFFECTS THE HER2-CDH1 INTERACTION
6. OC.13.4 THE ECM MOLECULE EMILIN-2 AFFECTS THE INFLAMMATORY RESPONSE VIA THE TLR-4/MYD88 PATHWAY IMPACTING ON COLORECTAL CANCER PATIENTS’ PROGNOSIS
7. AF.120 PCLE DETECTS MUCOSAL NEOPLASTIC VASCULAR PATTERN IN GASTRIC LINITIS PLASTICA
8. AF.72 MICROENCAPSULATED SODIUM BUTYRATE IN THE PREVENTION OF ACUTE RADIOTHERAPY PROCTITIS: SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY
9. AF.119 DISTINCTIVE VASCULAR PATTERNS HIGHLIGHTED BY PCLE IN GASTRIC DISEASES WITH HIGH RISK OF MALIGNANT COMPLICATIONS
10. OC.14.5 LANREOTIDE AND ENDOSCOPIC GASTROSTOMY IN INTESTINAL OCCLUSION FROM GYNAECOLOGICAL CANCERS: AVIANO NATIONAL CANCER INSTITUTE EXPERIENCE
11. Is FNA always necessary in submucosal lesion miming GIST?
12. Evaluation of neoangiogenesis in locally advanced gastric cancer before and after neoadjuvant radiochemotherapy by probe confocal laser endomicroscopy (PCLE)
13. P.05.34 EVALUATION OF NEOANGIOGENESIS IN LOCALLY ADVANCED GASTRIC CANCER BEFORE AND AFTER NEOADJUVANT RADIOCHEMOTHERAPY BY PROBE CONFOCAL LASER ENDOMICROSCOPY (PCLE)
14. P.05.35 IS ALWAYS NECESSARY FNA IN SUBMUCOSAL LESION MIMING GIST?
15. OC.04.4 EMILIN1 DEFICIENCY AFFECTS EXPERIMENTAL COLITIS AND COLON CARCINOGENESIS ENHANCING LYMPHATIC DYSFUNCTION
16. Genetic polymorphisms and PG1/PG2 and G17 levels can predict gastric carcinoids in autoimmune atrophic chronic gastritis patients
17. Gastric cancer in Lynch Syndrome: Are precancerous conditions co- risk factors?
18. P.01.13 METABOLOMICS AS COMPLEMENTARY OMIC APPROACH TO IMPLEMENT RISK CRITERIA FOR FIRST-DEGREE RELATIVES OF GASTRIC CANCER PATIENTS
19. P.01.15 IS IT POSSIBLE TO PREDICT THE PRESENCE GASTRIC CARCINOIDS IN AUTOIMMUNE ATROPHIC CHRONIC GASTRITIS PATIENTS?
20. OC.05.4 PRECANCEROUS CONDITIONS AS RISK FACTOR FOR GASTRIC CANCER IN LYNCH SYNDROME
21. P.08.2: Autoimmune Atrophic Gastritis is Associated with Other Autoimmune Diseases
22. P.08.10: Interference of PG2 Tata Box Region with the Serum PG2 Level in Gastric Cancer
23. P.08.1: Endoscopic Follow up can Predict Genetic Involvement in Attenuated Adenomatous Polyposis with no APC Or MUTYH Identified Mutations
24. Angiogenesis evaluation in locally advanced colo-rectal and gastric cancers by probe-based Confocal Laser Endomicroscopy (pCLE)
25. OC.04.2 GENETIC DIVERSITY OF THE KIR/HLA SYSTEM AND OUTCOME OF PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY
26. OC.04.7 IDENTIFICATION OF PROTEOMIC PROFILES ASSOCIATED WITH TUMOR REGRESSION GRADING IN RECTAL CANCER
27. P.09.7 PROGNOSTIC SIGNIFICANCE OF CLINICALLY METASTATIC MESORECTAL LYMPH NODES IN LOCALLY ADVANCED RECTAL CANCER TREATED BY NEOADJUVANT CHEMORADIATION: IMPLICATIONS FOR SURGICAL STRATEGIES IN RELATION TO PATHOLOGICAL RESPONSE
28. P-319 Angiogenesis evaluation in locally advanced colo-rectal and gastric cancers by probe-based Confocal Laser Endomicroscopy (pCLE)
29. OC.10.2 POST PROCEDURAL COMPLICATIONS RELATED TO DECOMPRESSIVE PERCUTANEUS ENDOSCOPIC GASTROSTOMY IN ADVANCED CANCER PATIENTS WITH PREVIOUS ABDOMINAL SURGERY
30. OC.13.1 IN VITRO CHARACTERIZATION OF CDH1 VARIANTS FIRST BY IMMORTALIZATION OF PERIPHERAL B-CELLS OF PATIENTS
31. P.16.6 AMINOPYRINE BREATH TEST AS A DIAGNOSTIC TOOL TO EVALUATE HEPATIC FUNCTIONAL RESERVE IN NEOPLASTIC PATIENTS RECEIVING HIGH DOSE CHEMOTHERAPY
32. OC.02.1 HELICOBACTER PYLORI VIRULENCE FACTORS IN FIRST DEGREE RELATIVES OF GASTRIC CANCER PATIENTS
33. P.07.19 THE PROTOTYPE LONGER MINIATURE ULTRASOUND MINIPROBE “UM-3Y2” IS USEFUL FOR DIAGNOSING SUBMUCOSAL LESION OF SMALL BOWEL DURING SINGLE-BALLOON ENTEROSCOPY (SBE)
34. P.09.11 EVALUATION OF GASTROPANEL IN GASTRIC CANCER (GC) PATIENTS, FIRST-DEGREE RELATIVES AND AUTOIMMUNE CHRONIC ATROPHIC GASTRITIS (ACAG)
35. P.13.9 PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY (PCLE) FOR IN VIVO EVALUATION OF THE TUMORAL VASCULATURE IN COLORECTAL CARCINOMA TREATED PATIENTS
36. P.07.5 CAPSULE ENDOSCOPY EVALUATION IN PATIENTS WITH CHRONIC DIARRHEA
37. OC.02.4 DIFFERENT PROTEIN EXPRESSION AND GENES PATTERNS OF HELICOBATER PYLORI IN PATHOLOGICAL DISORDERS OF THE GASTRIC MUCOSA
38. P.08.5 IDENTIFICATION OF CDH1 GERMLINE MUTATIONS IN SPORADIC GASTRIC CANCER PATIENTS AND SUBJECTS AT RISK TO DEVELOP GASTRIC CANCER
39. OC.01.6 PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY: IN VIVO ANALYSIS OF ANGIOGENESIS AS A NEW BASIS FOR A TRANSLATIONAL APPROACH FOR COLO-RECTAL AND GASTRIC CANCERS
40. P.08.11 EXOCRINE-ENDOCRINE MODULATION IN COMMON GASTRIC CARCINOMAS
41. P.17.10 EVALUATION OF CEA-IGM COMPLEXES IN THE DETECTION OF COLORECTAL CANCER
42. P.1.65: KIR AND HLA COMBINATIONS IN AUTOIMMUNE GASTRITIS AND GASTRIC CANCER SUSCEPTIBILITY
43. OC.01.5: WHAT FACTORS AFFECT THE QUALITY OF BOWEL PREPARATION FOR COLONOSCOPY? A MULTICENTER PROSPECTIVE COHORT STUDY
44. P.1.351: SERRATED ADENOMAS OF THE COLORECTUM: PREVALENCE IN ROUTINARY ENDOSCOPY PRACTICE
45. P.1.122: AUTOIMMUNE CHRONIC ATROPHIC GASTRITIS AND HELICOBACTER PYLORI: PREVALENCE OF THE INFECTION AND GENETIC HETEROGENEITY
46. P.105 AN UNUSUAL CASE OF PNEUMATOSIS CYSTOIDES GASTRO-INTESTINALIS CAUSED BY NON-HODGKIN LYMPHOMA
47. OC.06.2 CDH1 ANALYSIS AS A POSSIBLE MARKER FOR EARLY GASTRIC CANCER IN FIRST DEGREE GC-RELATIVES
48. P.40 KIR/HLA GENOTYPE ASSOCIATED WITH COMPLICATED CELIAC DISEASE
49. ANALYSIS OF MTHFR 677T SEGREGATION IN GASTRIC CANCER AND IN SUBJECTS WITH A FAMILY HISTORY OF GASTRIC CANCER
50. OC1.01.1 PPAR SIGNALLING PATHWAY IS INVOLVED IN CD-ASSOCIATED INFLAMMATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.